M. Paesmans (Brussels, Belgium), M. Pesek (Plzen, Czech Republic)
Prognosis of thymic epithelial tumors according to the new world health organization histologic classification
J. W. Moon, S. M. Kwak, M. S. Park, J. H. Chung, K. Y. Chung, K. D. Kim, W. I. Yang, Y. S. Kim, J. Chang, S. K. Kim, S. K. Kim (Seoul, Inchon, South Korea)
|   |
Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy
D. Christophe, B. Fabrice, T. Delphine, G. Roger, F. Pierre, A. Philippe, T. Pascal (Marseille, France)
| |
Relationship between pulmonary function and lung cancer surgery outcome
T. Win, C. Laroche, A. Jackson, A. M. Groves, A. Tasker (Cambridge, United Kingdom)
| |
Role of ras protoncogene in survival of patients with lung cancer: a systematic literature review and meta-analysis
C. Mascaux, N. Iannino, B. Martin, M. Paesmans, T. Berghmans, M. Dusart, A. Haller, P. Lothaire, A-P. Meert, J-J. Lafitte, J-P. Sculier (Brussels, Belgium; Lille, France)
| |
Evaluation of the role of EGFR as prognostic factor in stage III non-small cell lung cancer (NSCLC): a retrospective analysis
T. Berghmans, C. Mascaux, A. P. Meert, B. Martin, J. P. Sculier (Bruxelles, Belgium)
| |
Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy?
K. Junker, N. Albrecht, A. Linder, H. N. Macha, M. Thomas, K. M. Mueller (Bochum, Hemer, Muenster, Germany)
| |
Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC)
E. Jassem, K. Serkies, R. Dziadziuszko, A. Drozdowska, A. Urbaniak, S. Gozdz, G. Kobierska-Gulida, J. Skokowski, J. Jassem (Gdansk, Kielce, Poland)
| |
Impact of chemotherapy on survival in 587 NSCLCs: a retrospective study in a Belgian regional hospital
L. J. Siemons, J. Olbrecht (Sint-Truiden, Genval, Belgium)
| |